BioStock: PHI´s CEO comments on latest advancements

March 29, 2023
Language flag

In 2022, medtech company Phase Holographic Imaging conducted a rights issue that added over 57 million SEK to its coffers. Since then, and with a new focus on regenerative medicine, the company has been attracting more attention, not least by adding the Swiss investor company Altium as a new major shareholder. BioStock reached out to PHI´s CEO, Patrik Eschricht, to learn more about the visions moving forward.

Read the full interview with Patrik Eschricht on biostock.se.

Latest News

Phase Holographic Imaging logotype

Phase Holographic Imaging Announces Management Changes

Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development that lies ahead.

PHI announces last day of trading in BTA

Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ) 8 January 2025

Phase Holographic Imaging PHI AB (publ), held a general meeting on 8 January 2025. The following resolutions were made.
See All News